Cellectar Biosciences
CLRB
16 hedge funds and large institutions have $1.94M invested in Cellectar Biosciences in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
60% more funds holding
Funds holding: 10 → 16 (+6)
0.01% more ownership
Funds ownership: 0.05% → 0.05% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
34% less capital invested
Capital invested by funds: $2.92M → $1.94M (-$979K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
+$155K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$124K |
| 3 |
Renaissance Technologies
New York
|
+$74.3K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$27.4K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$8.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPFA
Game Plan Financial Advisors
Westlake,
Ohio
|
-$8.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BC
1
Boxer Capital
San Diego,
California
| $1.23M | – | – | – |
|
|
2
Renaissance Technologies
New York
| $309K | +$74.3K | +111 | +17% |
|
|
SFM
3
Sphera Funds Management
Tel Aviv,
Israel
| $111K | – | – | – |
|
|
FIA
4
FNY Investment Advisers
New York
| $88K | +$155K | +232 | New |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $71K | +$124K | +186 | New |
|
|
GPFA
6
Game Plan Financial Advisors
Westlake,
Ohio
| $51K | -$8.7K | -13 | -9% |
|
7
Vanguard Group
Malvern,
Pennsylvania
| $22K | – | – | – |
|
8
Morgan Stanley
New York
| $16K | – | – | – |
|
|
9
Citadel Advisors
Miami,
Florida
| $15K | +$27.4K | +41 | New |
|
10
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $13K | – | – | – |
|
|
11
Wells Fargo
San Francisco,
California
| $5K | +$8.7K | +13 | New |
|
12
US Bancorp
Minneapolis,
Minnesota
| $4K | – | – | – |
|
13
Victory Capital Management
San Antonio,
Texas
| $4K | +$6.69K | +10 | New |
|
14
Bank of America
Charlotte,
North Carolina
| $2K | +$3.35K | +5 | New |
|
15
UBS Group
Zurich,
Switzerland
| $1K | +$1.34K | +2 | New |
|
CLRB Hedge Fund Activity: Q1 2020 in Review
16 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences (CLRB) for Q1 2020, worth a combined $1.94M — down 34% from $2.92M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CLRB positions and 0 closed out — a net gain of 7 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was FNY Investment Advisers, opening a new position worth an estimated $155K. The largest seller was Game Plan Financial Advisors, cutting an estimated $8.7K.
- 16 institutional investors held Cellectar Biosciences (CLRB) as of Q1 2020, up from 10 in Q4 2019.
- Funds reported $1.94M of Cellectar Biosciences stock for Q1 2020, down 34% quarter-over-quarter.
- 7 funds opened new Cellectar Biosciences positions in Q1 2020 and 0 closed out, a net change of +7 holders.
- The largest Cellectar Biosciences buyer in Q1 2020 was FNY Investment Advisers, an estimated $155K added.
- The largest Cellectar Biosciences seller in Q1 2020 was Game Plan Financial Advisors, an estimated $8.7K sold.
Based on aggregated 13F filings for Q1 2020.